About this trial
This prospective clinical validation study aims to evaluate the diagnostic performance of an artificial intelligence (AI)-based navigational support system for determining fetal lie and presentation during third-trimester ultrasound examinations. Following routine clinical assessment by an expert clinician, three blind ultrasound sweeps will be obtained from each participant. The AI system will generate predictions of fetal lie and presentation from each sweep, which will be compared with the expert clinician's assessment as the reference standard. The study will also explore clinician perceptions of the system's usability and potential clinical value.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Pregnant women aged ≥18 years.
Singleton pregnancy.
Gestational age ≥28+0 weeks.
Fetus in longitudinal lie (cephalic or breech presentation) as determined by the routine clinical ultrasound examination.
Disqualifiers
Multiple pregnancy.
Fetus in transverse lie.
Inability to provide written informed consent.
Trial population
Pregnant women with singleton pregnancies attending third-trimester ultrasound examinations at the Fetal Medicine Department, Rigshospitalet, Slagelse Hospital, or Hillerød Hospital.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Diagnostic accuracy of the AI navigational support system for determining fetal lie and presentation.
Overall proportion of correct AI predictions of fetal lie and presentation compared with expert clinician assessment (reference standard).
Secondary outcomes
Agreement between AI predictions and expert clinician assessment.
Agreement will be evaluated using Cohen's kappa coefficient.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Copenhagen Academy for Medical Education and Simulation
Lead sponsor
Rigshospitalet, Denmark
Collaborator